We have developed ISA‐2011B, a novel selective inhibitor of PIP5K1α, that exhibits specific inhibitory effect on advanced PCa by inhibiting elevated levels of PI3K/Akt and AR [21, 23, 24]. The gene discussed is AKT1; the disease is posterior cortical atrophy.